Animal Drugs, Feeds, and Related Products; Chlortetracycline

Zusammenfassung

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of five supplemental new animal drug applications (NADA's) filed by Hoffmann-LaRoche, Inc., Pfizer, Inc., ALPHARMA, Inc., ADM Animal Health & Nutrition Div., and PennField Oil Co. The supplemental NADA's provide for the safe and effective use of Type A medicated articles containing chlortetracycline (CTC) in the feed of chickens, turkeys, swine, sheep, and calves, beef and nonlactating dairy cattle for improved production efficiency and for control and treatment of certain bacterial diseases susceptible to CTC. The approvals reflect compliance with results of the National Academy of Sciences/National Research Council (NAS/NRC), Drug Efficacy Study Group's (DESI) evaluation of the drug's effectiveness, and FDA's conclusions concerning that evaluation.